130 related articles for article (PubMed ID: 36472127)
1. Multi-specific niflumic acid platinum(IV) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage.
Li L; Zhang M; Jia D; Liu Z; Zhang N; Sun B; Wang Z; Liu M; Wang Q
Dalton Trans; 2022 Dec; 52(1):147-158. PubMed ID: 36472127
[TBL] [Abstract][Full Text] [Related]
2. Development of Clioquinol Platinum(IV) Conjugates as Autophagy-Targeted Antimetastatic Agents.
Zhang M; Li L; Li S; Liu Z; Zhang N; Sun B; Wang Z; Jia D; Liu M; Wang Q
J Med Chem; 2023 Mar; 66(5):3393-3410. PubMed ID: 36891739
[TBL] [Abstract][Full Text] [Related]
3. A series of ligustrazine platinum(IV) complexes with potent anti-proliferative and anti-metastatic properties that exert chemotherapeutic and immunotherapeutic effects.
Chen Y; Li L; Liu Z; Liu M; Wang Q
Dalton Trans; 2023 Sep; 52(37):13097-13109. PubMed ID: 37664893
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of dihydro-2-quinolone platinum(iv) hybrids as antitumor agents displaying mitochondria injury and DNA damage mechanism.
Liu Z; Li Z; Du T; Chen Y; Wang Q; Li G; Liu M; Zhang N; Li D; Han J
Dalton Trans; 2021 Jan; 50(1):362-375. PubMed ID: 33319888
[TBL] [Abstract][Full Text] [Related]
5. Ketoprofen and Loxoprofen Platinum(IV) Complexes Displaying Antimetastatic Activities by Inducing DNA Damage, Inflammation Suppression, and Enhanced Immune Response.
Li Z; Wang Q; Li L; Chen Y; Cui J; Liu M; Zhang N; Liu Z; Han J; Wang Z
J Med Chem; 2021 Dec; 64(24):17920-17935. PubMed ID: 34852203
[TBL] [Abstract][Full Text] [Related]
6. Development of a series of flurbiprofen and zaltoprofen platinum(IV) complexes with anti-metastasis competence targeting COX-2, PD-L1 and DNA.
Li Z; Li L; Zhao W; Sun B; Liu Z; Liu M; Han J; Wang Z; Li D; Wang Q
Dalton Trans; 2022 Aug; 51(33):12604-12619. PubMed ID: 35924963
[TBL] [Abstract][Full Text] [Related]
7. A potent aminonaphthalimide platinum(IV) complex with effective antitumor activities in vitro and in vivo displaying dual DNA damage effects on tumor cells.
Wang Q; Chen Y; Li G; Zhao Y; Liu Z; Zhang R; Liu M; Li D; Han J
Bioorg Med Chem Lett; 2019 Oct; 29(20):126670. PubMed ID: 31500997
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of antitumor platinum(II) agents conjugated with non-steroidal anti-inflammatory drug species.
Zang J; Zhang B; Wang Y; Wang X; Gou S
Bioorg Chem; 2022 Mar; 120():105633. PubMed ID: 35091288
[TBL] [Abstract][Full Text] [Related]
9. Series of Desloratadine Platinum(IV) Hybrids Displaying Potent Antimetastatic Competence by Inhibiting Epithelial-Mesenchymal Transition and Arousing Immune Response.
Zhang M; Chen Y; Liu Z; Liu M; Wang Q
J Med Chem; 2024 Feb; 67(3):2031-2048. PubMed ID: 38232132
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of a new series of low toxic naphthalimide platinum(IV) antitumor complexes with dual DNA damage mechanism.
Wang Q; Tan X; Liu Z; Li G; Zhang R; Wei J; Wang S; Li D; Wang B; Han J
Eur J Pharm Sci; 2018 Nov; 124():127-136. PubMed ID: 30153524
[TBL] [Abstract][Full Text] [Related]
11. Naproxen platinum(iv) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo.
Chen Y; Wang Q; Li Z; Liu Z; Zhao Y; Zhang J; Liu M; Wang Z; Li D; Han J
Dalton Trans; 2020 Apr; 49(16):5192-5204. PubMed ID: 32236281
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of a novel series of glycosylated platinum(iv) complexes as antitumor agents.
Wang Q; Huang Z; Ma J; Lu X; Zhang L; Wang X; George Wang P
Dalton Trans; 2016 Jun; 45(25):10366-74. PubMed ID: 27252024
[TBL] [Abstract][Full Text] [Related]
13. A novel star-shaped trinuclear platinum(II) complex based on a 1,3,5-triazine core displaying potent antiproliferative activity against TNBC by the mitochondrial injury and DNA damage mechanism.
Wu Y; Zhao D; Shang J; Huang W; Chen Z
Dalton Trans; 2022 Jul; 51(29):10930-10942. PubMed ID: 35731536
[TBL] [Abstract][Full Text] [Related]
14. Dual-target platinum(IV) complexes exhibit antiproliferative activity through DNA damage and induce ER-stress-mediated apoptosis in A549 cells.
Wang M; Liu Z; Huang X; Chen Y; Wang Y; Kong J; Yang Y; Yu C; Li J; Wang X; Wang H
Bioorg Chem; 2021 May; 110():104741. PubMed ID: 33647739
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
[TBL] [Abstract][Full Text] [Related]
16. Novel Platinum(IV) complexes intervene oxaliplatin resistance in colon cancer via inducing ferroptosis and apoptosis.
Liu Z; Cai J; Jiang G; Wang M; Wu C; Su K; Hu W; Huang Y; Yu C; Huang X; Cao G; Wang H
Eur J Med Chem; 2024 Jan; 263():115968. PubMed ID: 37995563
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo anti-tumor effects of selected platinum(IV) and dinuclear platinum(II) complexes against lung cancer cells.
Arsenijevic M; Milovanovic M; Jovanovic S; Arsenijevic N; Markovic BS; Gazdic M; Volarevic V
J Biol Inorg Chem; 2017 Aug; 22(6):807-817. PubMed ID: 28421385
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
19. Fresh platinum complexes with promising antitumor activity.
Wang X
Anticancer Agents Med Chem; 2010 Jun; 10(5):396-411. PubMed ID: 20545618
[TBL] [Abstract][Full Text] [Related]
20. Dual-targeting antitumor conjugates derived from platinum(IV) prodrugs and microtubule inhibitor CA-4 significantly exhibited potent ability to overcome cisplatin resistance.
Huang X; Wang M; Wang C; Hu W; You Q; Yang Y; Yu C; Liao Z; Gou S; Wang H
Bioorg Chem; 2019 Nov; 92():103236. PubMed ID: 31494328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
